PREGNYL

This brand name is authorized in Australia, Austria, Canada, Estonia, Finland, Germany, Lithuania, Netherlands, New Zealand, Poland, Singapore.

Active ingredients

The drug PREGNYL contains one active pharmaceutical ingredient (API):

1	human Chorionic Gonadotropin, hCG UNII 20ED16GHEB - CHORIONIC GONADOTROPIN
	Human chorionic gonadotrophin stimulates the steroidogenesis in the gonads by virtue of a biological effect similar to that of LH (Luteinizing hormone, which is the same as interstitial cell stimulating hormone).
	Read more about Chorionic gonadotrophin (human)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PREGNYL 5000IU Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GA01	Chorionic gonadotrophin	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11148R, 11154C, 11156E
CA	Health Products and Food Branch	02182904
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	15319865
EE	Ravimiamet	1022555, 1398483
FI	Lääkealan turvallisuus- ja kehittämiskeskus	563784
LT	Valstybinė vaistų kontrolės tarnyba	1081247, 1081248
NL	Z-Index G-Standaard	12142433, 14934655
NL	Z-Index G-Standaard, PRK	6866, 6874
NZ	Medicines and Medical Devices Safety Authority	4824, 4825
PL	Rejestru Produktów Leczniczych	100054837, 100422761, 100436065, 100451014
SG	Health Sciences Authority	04384P